Alecensaro (alectinib)

pCPA File Number: 21076
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-Small Cell Lung Cancer (First Line)
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0125-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: